UK Markets closed

Grifols, S.A. (GRF.MC)

MCE - MCE Delayed price. Currency in EUR
Add to watchlist
12.52-0.04 (-0.28%)
At close: 05:35PM CET
Full screen
Previous close12.56
Open12.52
Bid12.52 x 0
Ask12.55 x 0
Day's range12.48 - 12.70
52-week range7.82 - 20.28
Volume1,091,054
Avg. volume1,692,339
Market cap7.337B
Beta (5Y monthly)0.33
PE ratio (TTM)13.92
EPS (TTM)0.90
Earnings date28 Jul 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date03 Jun 2021
1y target est19.83
  • Reuters

    Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit

    Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on track to meet its full-year financial targets, but its shares fell 4.2% in morning trade. The company, which uses blood plasma to make medicines, saw its business severely hit by the pandemic as blood collection was halted in many countries.

  • Reuters

    Grifols says U.S. blood donors' lawsuit won't have material impact, shares down

    Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no material impact, after a report in newspaper El Economista sent the shares sharply lower. The company said about 54,000 donors in Illinois had filed a lawsuit claiming Grifols breached data protection regulations, confirming the newspaper report. Grifols shares were down 5.3% on Friday morning, briefly the worst performer on the blue-chip Ibex-35 index, which was down 2.1%.

  • Reuters

    Grifols appoints executive chairman as seeks to speed recovery

    Grifols appointed an executive chairman on Monday, as the Spanish pharmaceutical company strives to recover from a pandemic-related hit and a 49% drop in its shares so far this year. Steven F. Mayer, an independent board member since 2011 and a former senior managing director of Cerberus Global Private Equity, will become executive chairman, effective immediately. The company's outgoing non-executive chairman, Victor Grifols Roura, who was chief executive from 1987 to 2016, has been named honorary chairman.